The amyloid precursor protein (APP) plays an essential role in Alzheimer’s disease (AD), since sequential cleavages of β- and γ-secretase lead to the formation of the 4 kDa Aβ peptide, which accumulates in brains of AD patients [1]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.